- Home
- NTZ vs LVTX Comparison
NTZ vs LVTX Comparison
Compare NTZ & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- LVTX
- Stock Information
- Founded
- NTZ 1959
- LVTX 2016
- Country
- NTZ Italy
- LVTX Netherlands
- Employees
- NTZ N/A
- LVTX N/A
- Industry
- NTZ Home Furnishings
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- LVTX Health Care
- Exchange
- NTZ Nasdaq
- LVTX Nasdaq
- Market Cap
- NTZ 37.2M
- LVTX 40.8M
- IPO Year
- NTZ 1993
- LVTX 2021
- Fundamental
- Price
- NTZ $2.80
- LVTX $1.60
- Analyst Decision
- NTZ
- LVTX Hold
- Analyst Count
- NTZ 0
- LVTX 4
- Target Price
- NTZ N/A
- LVTX $1.58
- AVG Volume (30 Days)
- NTZ 2.1K
- LVTX 439.0K
- Earning Date
- NTZ 04-13-2023
- LVTX 08-13-2025
- Dividend Yield
- NTZ N/A
- LVTX N/A
- EPS Growth
- NTZ N/A
- LVTX N/A
- EPS
- NTZ N/A
- LVTX N/A
- Revenue
- NTZ $337,653,480.00
- LVTX $4,990,000.00
- Revenue This Year
- NTZ N/A
- LVTX N/A
- Revenue Next Year
- NTZ N/A
- LVTX N/A
- P/E Ratio
- NTZ N/A
- LVTX N/A
- Revenue Growth
- NTZ N/A
- LVTX N/A
- 52 Week Low
- NTZ $2.15
- LVTX $0.85
- 52 Week High
- NTZ $6.27
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- NTZ 37.44
- LVTX 58.95
- Support Level
- NTZ $3.05
- LVTX $1.53
- Resistance Level
- NTZ $3.40
- LVTX $1.64
- Average True Range (ATR)
- NTZ 0.11
- LVTX 0.05
- MACD
- NTZ -0.08
- LVTX 0.00
- Stochastic Oscillator
- NTZ 0.00
- LVTX 85.42
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.